0 Yorumlar
0 hisse senetleri
492 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Genetic Engineering Plant Genomics Market Expanding Industry Potential"According to the latest report published by Data Bridge Market Research, the Genetic Engineering Plant Genomics Market Data Bridge Market Research analyses that the global genetic engineering plant genomics market which was USD 9.04 billion in 2022, is expected to reach USD 17.46 billion by 2030, growing at a CAGR of 8.7% during the forecast period of 2023 to 2030. Market research...0 Yorumlar 0 hisse senetleri 132 Views 0 önizleme
-
Genomics Market Expansion Through Next Generation SequencingThe Genomics Market is undergoing a fundamental shift as diagnostic providers increasingly pivot toward genomic-based testing for common and complex conditions. No longer limited to rare genetic disorders, genomic testing is now routinely used to screen for cardiovascular risks, hereditary cancers, and metabolic disorders. This shift is supported by growing public awareness and the entry of...0 Yorumlar 0 hisse senetleri 267 Views 0 önizleme
-
qPCR Instruments Market Investment Opportunities and ForecastThe global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...0 Yorumlar 0 hisse senetleri 655 Views 0 önizleme
-
Rare Disease Genetic Testing Market Competitive Analysis and Key PlayersThe global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...0 Yorumlar 0 hisse senetleri 674 Views 0 önizleme